Could this Healthcare Stock really climb 1,437.41% by 2024?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [BREAKING: The Return Of The Gold Standard?]( [After 89 long years… is this the return of the gold standard? Click here now for all of the details.]( --------------------------------------------------------------- November 13, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Saudis joined BRICS to attack America?]( Our former ally Saudi Arabia just officially aligned with Russia, China, and Iran… [>>Saudi Arabia preparing “weapon of mass destruction”<<]( --------------------------------------------------------------- [Canoo]( Symbol: [GOEV]( Recent Price: $0.25 Average Analyst Price Target: $4.50 (1,744.90%) Market Cap: $176.20M Last Year's EPS: -$0.17 Consensus EPS Forecast: -$0.19 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Jaime Perez, analyst at R.F. Lafferty, reiterates coverage on [Canoo (GOEV)]( in the Technology sector with a Buy rating and a price target of $2 (2 months ago). [TipRanks.com]( also reports that [Canoo]( currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $4.50 . The target pricing ranges from a high forecast of $2 down to a low forecast of $1.5. [Canoo (GOEV)](’s last closing price was $0.25 which would put the average price target at 1,744.90% upside. Here are 3rd party ratings for [GOEV](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 41% (148 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Drive Coast to Coast on a Single Charge]( brand-new battery technology could soon power EVs for 1,000 miles — on a single charge. To put that in perspective... - If you were to drive a Nissan Leaf from coast to coast, you’d have to recharge the battery eight times… - A Chevy Bolt, seven times… - Even the Tesla Model X would need to be charged six times. - And you’d have to hang around for anywhere between one and 12 hours at each charging station. - But with this new battery technology in your vehicle, you’d only have to recharge ONCE … in a matter of minutes. The company that pioneered this new technology could be the investment of a lifetime. [Watch this video for the details.]( --------------------------------------------------------------- [Heron Therapeutics]( Symbol: [HRTX]( Recent Price: $0.59 Average Analyst Price Target: $7.17 (1,437.41%) Market Cap: $82.40M Last Year's EPS: -$0.27 Consensus EPS Forecast: -$0.23 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Boris Peaker, analyst at TD Cowen, reiterates coverage on [Heron Therapeutics (HRTX)]( in the Healthcare sector with a Buy rating and a price target of $5.5 (6 months ago). [TipRanks.com]( also reports that [Heron Therapeutics]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $7.17 . The target pricing ranges from a high forecast of $6 down to a low forecast of $10. [Heron Therapeutics (HRTX)](’s last closing price was $0.59 which would put the average price target at 1,437.41% upside. Here are 3rd party ratings for [HRTX](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 31% (78 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Sigma Lithium]( Symbol: [SGML]( Recent Price: $21.77 Average Analyst Price Target: $45.60 (103.86%) Market Cap: $2.39B Last Year's EPS: -$0.53 Consensus EPS Forecast: -$0.2 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Katie Lachapelle, analyst at Canaccord Genuity, reiterates coverage on [Sigma Lithium (SGML)]( in the Energy sector with a Buy rating and a price target of $47.1 (1 week ago). [TipRanks.com]( also reports that [Sigma Lithium]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $45.60 . The target pricing ranges from a high forecast of $49.28 down to a low forecast of $42. [Sigma Lithium (SGML)](’s last closing price was $21.77 which would put the average price target at 103.86% upside. Here are 3rd party ratings for [SGML](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 45% (138 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [CureVac]( Symbol: [CVAC]( Recent Price: $5.41 Average Analyst Price Target: $17.25 (189.65%) Market Cap: $1.21B Last Year's EPS: -$0.29 Consensus EPS Forecast: -$0.28 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Eun Yang, analyst at Jefferies, reiterates coverage on [CureVac (CVAC)]( in the Healthcare sector with a Buy rating and a price target of $21 (1 month ago). [TipRanks.com]( also reports that [CureVac]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $17.25 . The target pricing ranges from a high forecast of $8 down to a low forecast of $18. [CureVac (CVAC)](’s last closing price was $5.41 which would put the average price target at 189.65% upside. Here are 3rd party ratings for [CVAC](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 26% (64 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [FiscalNote Holdings]( Symbol: [NOTE]( Recent Price: $1.30 Average Analyst Price Target: $5.81 (419.23%) Market Cap: $167.51M Last Year's EPS: -$0.11 Consensus EPS Forecast: -$0.12 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Matthew VanVliet, analyst at BTIG, reiterates coverage on [FiscalNote Holdings (NOTE)]( in the Technology sector with a Buy rating and a price target of $4.5 (1 month ago). [TipRanks.com]( also reports that [FiscalNote Holdings]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.81 . The target pricing ranges from a high forecast of $9 down to a low forecast of $4.5. [FiscalNote Holdings (NOTE)](’s last closing price was $1.30 which would put the average price target at 419.23% upside. Here are 3rd party ratings for [NOTE](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 34% (86 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This Stock Could Go Up 66% or More.]( Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. [More here.]( --------------------------------------------------------------- [Northern Dynasty Minerals]( Symbol: [NAK]( Recent Price: $0.33 Average Analyst Price Target: $0.90 (172.56%) Market Cap: $172.82M Last Year's EPS: -$0.01 Consensus EPS Forecast: -$0.01 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Heiko Ihle, analyst at H.C. Wainwright, reiterates coverage on [Northern Dynasty Minerals (NAK)]( in the Basic Materials sector with a Buy rating and a price target of $0.9 (1 month ago). [TipRanks.com]( also reports that [Northern Dynasty Minerals]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $0.90 . The target pricing ranges from a high forecast of $0.9 down to a low forecast of $0.9. [Northern Dynasty Minerals (NAK)](’s last closing price was $0.33 which would put the average price target at 172.56% upside. Here are 3rd party ratings for [NAK](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 35% (88 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Stronghold Digital Mining]( Symbol: [SDIG]( Recent Price: $3.89 Average Analyst Price Target: $13.67 (234.19%) Market Cap: $38.14M Last Year's EPS: -$1.2 Consensus EPS Forecast: -$1.27 Expected Earnings Date: Nov 14 2023 Recent Analyst Action: Chase White, analyst at Compass Point, reiterates coverage on [Stronghold Digital Mining (SDIG)]( in the Technology sector with a Buy rating and a price target of $13 (3 weeks ago). [TipRanks.com]( also reports that [Stronghold Digital Mining]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $13.67 . The target pricing ranges from a high forecast of $8 down to a low forecast of $13. [Stronghold Digital Mining (SDIG)](’s last closing price was $3.89 which would put the average price target at 234.19% upside. Here are 3rd party ratings for [SDIG](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 34% (86 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Gold is about to SOAR – here’s what you need to do]( is lining up perfectly for a historic gold bull run. One gold research firm says they’ve found the best way to get in, for less than $5. --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software